Revenue: The sum of all revenue fields included for a company's operating activities.
Cue Biopharma, Inc. (CUE) had Revenue of $1.58M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$1.58M |
$-9.50M |
|
-- |
|
$1.58M |
|
$11.21M |
|
$-9.63M |
|
$0.14M |
|
$-9.50M |
|
$-9.50M |
|
$-9.50M |
|
$-9.50M |
|
$-9.50M |
|
$-9.50M |
|
$-9.63M |
|
$-9.53M |
|
56.33M |
|
56.33M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$25.14M |
|
$0.47M |
|
$7.05M |
|
$32.19M |
|
$13.69M |
|
-- |
|
$1.00M |
|
$14.69M |
|
$17.50M |
|
$17.50M |
|
$17.50M |
|
61.82M |
|
| Cash Flow Statement Financials | |
$-36.33M |
|
$0.03M |
|
$10.24M |
|
$48.66M |
|
$22.61M |
|
$-26.05M |
|
$6.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
100.00% |
|
-611.29% |
|
-611.29% |
|
-- |
|
-602.54% |
|
-602.54% |
|
$-36.30M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
1.67 |
|
53.97 |
|
-54.27% |
|
-54.27% |
|
-29.50% |
|
-54.27% |
|
$0.28 |
|
$-0.64 |
|
$-0.65 |
|